Literature DB >> 30650007

Rejection Sensitivity and Borderline Personality Disorder Features: The Mediating Roles of Attachment Anxiety, Need to Belong, and Self-Criticism.

Momoko Sato1, Peter Fonagy1, Patrick Luyten2.   

Abstract

Rejection hypersensitivity has been considered the core feature of patients with borderline personality disorder (BPD). However, little is known about the possible developmental mechanisms that might explain the association between rejection sensitivity and BPD features. The current study investigated the mediating roles of adult attachment, need to belong, and self-criticism in the association between rejection sensitivity and BPD features in 256 healthy adults. Results indicated that attachment anxiety, need to belong, and self-criticism mediated the association between rejection sensitivity and BPD features. However, attachment anxiety and self-criticism did not moderate the mediated association between rejection sensitivity and BPD features. The findings suggest that individuals with high rejection sensitivity are more likely to be anxiously attached to significant others, which might increase the desire to be accepted by others. To satisfy this elevated need to affiliate with others, these individuals might become more self-critical, which may contribute to high BPD features.

Entities:  

Keywords:  attachment anxiety; borderline personality features; need to belong; rejection sensitivity; self-criticism

Mesh:

Year:  2019        PMID: 30650007     DOI: 10.1521/pedi_2019_33_397

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  2 in total

1.  Unextracted plasma oxytocin levels decrease following in-laboratory social exclusion in young adults with a suicide attempt history.

Authors:  Carol Chu; Elizabeth A D Hammock; Thomas E Joiner
Journal:  J Psychiatr Res       Date:  2019-11-22       Impact factor: 4.791

2.  High Rejection Sensitivity in Patients With Somatoform Pain Disorder.

Authors:  Yeliz Nacak; Eva Morawa; Yesim Erim
Journal:  Front Psychiatry       Date:  2021-03-29       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.